The up-regulation of SLP2 was shown to be significantly correlated with the World Health Organization (WHO) histological grade of gliomas, while patients with higher SLP2 expression levels had an overall shorter survival time compared to patients with a lower expression of SLP2 [24]. The gene discussed is STOML2; the disease is glioma.